Aarti Pharmalabs Limited (BOM:543748)
816.60
-12.70 (-1.53%)
At close: Aug 21, 2026
Aarti Pharmalabs Revenue
Aarti Pharmalabs had revenue of 5.36B INR in the quarter ending June 30, 2026, with 38.74% growth. This brings the company's revenue in the last twelve months to 19.69B, up 1.20% year-over-year. In the fiscal year ending March 31, 2026, Aarti Pharmalabs had annual revenue of 18.19B, down -13.98%.
Revenue (ttm)
19.69B
Revenue Growth
+1.20%
P/S Ratio
3.76
Revenue / Employee
9.11M
Employees
2,162
Market Cap
74.05B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.19B | -2.96B | -13.98% |
| Mar 31, 2025 | 21.15B | 2.62B | 14.17% |
| Mar 31, 2024 | 18.53B | -926.24M | -4.76% |
| Mar 31, 2023 | 19.45B | 7.45B | 62.11% |
| Mar 31, 2022 | 12.00B | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 86.08B |
| Viyash Scientific | 35.75B |
| FDC Limited | 21.90B |
| Morepen Laboratories | 19.51B |
| Sanofi India | 18.05B |
| CORONA Remedies | 14.79B |
| Procter & Gamble Health | 14.33B |
| Bliss GVS Pharma | 10.05B |